DK1242119T3 - Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid - Google Patents

Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid

Info

Publication number
DK1242119T3
DK1242119T3 DK00981499T DK00981499T DK1242119T3 DK 1242119 T3 DK1242119 T3 DK 1242119T3 DK 00981499 T DK00981499 T DK 00981499T DK 00981499 T DK00981499 T DK 00981499T DK 1242119 T3 DK1242119 T3 DK 1242119T3
Authority
DK
Denmark
Prior art keywords
treatment
viral infections
combinations
cardiac glycoside
dna viral
Prior art date
Application number
DK00981499T
Other languages
English (en)
Inventor
Christopher Edward Hartley
Original Assignee
Henderson Morley Res & Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930811.6A external-priority patent/GB9930811D0/en
Priority claimed from GB0000683A external-priority patent/GB0000683D0/en
Priority claimed from GB0023198A external-priority patent/GB0023198D0/en
Application filed by Henderson Morley Res & Dev Ltd filed Critical Henderson Morley Res & Dev Ltd
Application granted granted Critical
Publication of DK1242119T3 publication Critical patent/DK1242119T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK00981499T 1999-12-30 2000-12-13 Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid DK1242119T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9930811.6A GB9930811D0 (en) 1999-10-15 1999-12-30 Anti-viral treatment
GB0000683A GB0000683D0 (en) 1999-10-15 2000-01-12 Antiviral treatment
GB0023198A GB0023198D0 (en) 1999-12-30 2000-09-21 Treatment of DNA viral infections
PCT/GB2000/004793 WO2001049242A2 (en) 1999-12-30 2000-12-13 Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Publications (1)

Publication Number Publication Date
DK1242119T3 true DK1242119T3 (da) 2004-08-02

Family

ID=27255465

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00981499T DK1242119T3 (da) 1999-12-30 2000-12-13 Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid

Country Status (17)

Country Link
US (1) US6894030B2 (da)
EP (1) EP1242119B1 (da)
JP (1) JP2003519163A (da)
KR (1) KR100843790B1 (da)
CN (1) CN1414863A (da)
AT (1) ATE261737T1 (da)
AU (1) AU777339B2 (da)
BR (1) BR0016831A (da)
CA (1) CA2395016C (da)
DE (1) DE60009146T2 (da)
DK (1) DK1242119T3 (da)
ES (1) ES2218254T3 (da)
IL (1) IL150286A0 (da)
MX (1) MXPA02006489A (da)
PT (1) PT1242119E (da)
TR (1) TR200401363T4 (da)
WO (1) WO2001049242A2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
GB2376628B (en) * 2001-06-19 2005-06-08 Henderson Morley Res & Dev Ltd Treatment of DNA viral infections in cats
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment
WO2002024207A1 (en) * 2000-09-21 2002-03-28 Henderson Morley Research & Development Limited Diuretic or sulphonylurea for use in antiviral treatment
US7534768B2 (en) * 2000-12-13 2009-05-19 Henderson Morely Research And Development Ltd. Treatment of DNA viral infections
AU2003240818B2 (en) * 2002-05-28 2006-05-04 Bette Pollard Cardiac glycosides to treat cystic fibrosis and other IL-8 dependent disorders
DE10223932A1 (de) * 2002-05-29 2003-12-18 Rudolf Wank Verwendung von Diuretika zur Behandlung von Schwellungen
EP2305243A1 (en) 2003-02-12 2011-04-06 Georgetown University Use of artemisinin and related compounds for treating diseases induced by human papilloma virus
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
GB0517838D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Transdermal active principle delivery means
GB0517840D0 (en) * 2005-09-02 2005-10-12 Henderson Morley Plc Topical anti viral formulations
WO2007047447A2 (en) * 2005-10-17 2007-04-26 Neurotherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
GB0616451D0 (en) * 2006-08-18 2006-09-27 Henderson Morley Plc Dna viral infections
CN106562982A (zh) * 2016-09-27 2017-04-19 苏州系统医学研究所 强心苷类化合物在抗埃博拉病毒感染中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03240732A (ja) * 1990-02-14 1991-10-28 Yasuo Tanaka 抗ウイルス剤
US7071230B2 (en) * 1997-10-02 2006-07-04 Board Of Trustees Of Southern Illinois University Therapeutic use of D-methionine to reduce the toxicity of noise
WO2000010574A1 (en) * 1998-08-24 2000-03-02 Hadasit Medical Research Services And Development Ltd. The use of loop diuretics for hiv infection
EP1242096B1 (en) * 1999-12-30 2005-10-12 Henderson Morley Research and Development Limited Pharmaceutucal compositions for the treatment of dna viral infections comprising a loop diuretic and lithium

Also Published As

Publication number Publication date
DE60009146D1 (de) 2004-04-22
WO2001049242A2 (en) 2001-07-12
PT1242119E (pt) 2004-08-31
ATE261737T1 (de) 2004-04-15
WO2001049242A3 (en) 2002-07-11
BR0016831A (pt) 2002-09-10
MXPA02006489A (es) 2003-09-22
AU1873401A (en) 2001-07-16
AU777339B2 (en) 2004-10-14
EP1242119A2 (en) 2002-09-25
JP2003519163A (ja) 2003-06-17
KR20030005162A (ko) 2003-01-17
CA2395016A1 (en) 2001-07-12
US6894030B2 (en) 2005-05-17
DE60009146T2 (de) 2005-02-17
US20030050253A1 (en) 2003-03-13
CN1414863A (zh) 2003-04-30
TR200401363T4 (tr) 2004-08-23
ES2218254T3 (es) 2004-11-16
KR100843790B1 (ko) 2008-07-03
EP1242119B1 (en) 2004-03-17
CA2395016C (en) 2009-04-14
IL150286A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
DK1242119T3 (da) Kombinationer til behandling af DNA-virale infektioner omfattende et loop-diuretikum og et hjerteglycosid
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
DE60031248D1 (de) Elektroaktive pore
NO20023043L (no) Substituerte oksazolidinoner og deres anvendelse innenfor feltet blodkoagulasjon
NO954635L (no) Ribozymgenterapi for HIV infeksjoner og AIDS
DK1021410T3 (da) Prostaglandinagonister og deres anvendelse til behandling af knogletilstande
DK1212317T3 (da) Indolderivater og anvendelse deraf til behandling af osteoporose blandt andre anvendelser
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO882807L (no) Herdbare blandinger og deres anvendelse.
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
DK0983271T3 (da) Carbocyklisk nucleosidhemisulfat og anvendelsen deraf i behandlingen af virusinfektioner
DK147088A (da) Middel til behandling af virale infektioner i mennesker
NO991581D0 (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
DK35588A (da) Hoejniveau-ekspression i e. coli af oploeseligt, modent humant interleukin-1beta og derivater med aendret biologisk virkning
AU1873101A (en) Synergistic treatment of dna viral infections
NO892570D0 (no) Polysilazaner, deres fremstilling og anvendelse.
ATE246930T1 (de) Behandlung von chronischer viraler infektion mit m. vaccae
BR0012380A (pt) 2-amino-benzoxazinonas para o tratamento de vìrus do herpes simples
ES2195861T3 (es) Uso de (ir,4s)-4-(6-amino-9h-purin-9-il)-2-ciclopenten-1-metanol en vhb.
PT958290E (pt) Derivados de 1,4-di-hidropiridina e seu uso em terapia
NO894821D0 (no) Homopolysakkarid, opploesning derav, og deres fremstillingog anvendelse.
DK10593D0 (da) Heterocycliske forbindelser, deres fremstilling og anvendelse
NO920228L (no) Polylaktider, deres fremstilling og anvendelse